Herceptin Biosimilar Market Size is expected to be worth USD 11,287 Million by 2030 at a CAGR of 23.2%, Owing to Rising Prevalence and Incidence of Gastric and Breast Cancer
August 22, 2022 09:02 ET
|
Acumen Research and Consulting
LOS ANGELIS, Aug. 22, 2022 (GLOBE NEWSWIRE) -- , August 22, 2022 (GLOBE NEWSWIRE) – The Global Herceptin Biosimilar Market Size was valued at USD 1,795 Million in 2021 and is predicted to be worth...